83 related articles for article (PubMed ID: 18070816)
1. Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome.
Kulik W; van Lenthe H; Stet FS; Houtkooper RH; Kemp H; Stone JE; Steward CG; Wanders RJ; Vaz FM
Clin Chem; 2008 Feb; 54(2):371-8. PubMed ID: 18070816
[TBL] [Abstract][Full Text] [Related]
2. FGF21 and GDF15 are elevated in Barth Syndrome and are correlated to important clinical measures.
Liu O; Chinni BK; Manlhiot C; Vernon HJ
Mol Genet Metab; 2023 Nov; 140(3):107676. PubMed ID: 37549445
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER.
Thompson WR; Manuel R; Abbruscato A; Carr J; Campbell J; Hornby B; Vaz FM; Vernon HJ
Genet Med; 2024 Apr; 26(7):101138. PubMed ID: 38602181
[TBL] [Abstract][Full Text] [Related]
4. Higher IL-6 and IL6:IGF Ratio in Patients with Barth Syndrome.
Wilson LD; Al-Majid S; Rakovski CS; Schwindt CD
J Inflamm (Lond); 2012 Jun; 9(1):25. PubMed ID: 22721508
[TBL] [Abstract][Full Text] [Related]
5. A monolysocardiolipin-cytochrome c peroxidase causes defects in Barth syndrome.
Nat Metab; 2023 Dec; 5(12):2043-2044. PubMed ID: 38049582
[No Abstract] [Full Text] [Related]
6. Arginine kinetics are altered in a pilot sample of adolescents and young adults with Barth syndrome.
Cade WT; Bohnert KL; Bittel AJ; Chacko SJ; Patterson BW; Pacak CA; Byrne BJ; Vernon HJ; Reeds DN
Mol Genet Metab Rep; 2020 Dec; 25():100675. PubMed ID: 33204638
[TBL] [Abstract][Full Text] [Related]
7. Urea Cycle Related Amino Acids Measured in Dried Bloodspots Enable Long-Term In Vivo Monitoring and Therapeutic Adjustment.
Baruteau J; Khalil Y; Grunewald S; Zancolli M; Chakrapani A; Cleary M; Davison J; Footitt E; Waddington SN; Gissen P; Mills P
Metabolites; 2019 Nov; 9(11):. PubMed ID: 31718089
[TBL] [Abstract][Full Text] [Related]
8. "I Want That Life a Lot…How on Earth Do I Get That?" Examining Challenges for Men With Barth Syndrome in Their Transitions to Adulthood.
Mazar I; Moorman SM
J Patient Exp; 2021; 8():23743735211060783. PubMed ID: 34869844
[TBL] [Abstract][Full Text] [Related]
9. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.
Houtkooper RH; Rodenburg RJ; Thiels C; van Lenthe H; Stet F; Poll-The BT; Stone JE; Steward CG; Wanders RJ; Smeitink J; Kulik W; Vaz FM
Anal Biochem; 2009 Apr; 387(2):230-7. PubMed ID: 19454236
[TBL] [Abstract][Full Text] [Related]
10. Advances in methods to analyse cardiolipin and their clinical applications.
Bautista JS; Falabella M; Flannery PJ; Hanna MG; Heales SJR; Pope SAS; Pitceathly RDS
Trends Analyt Chem; 2022 Dec; 157():116808. PubMed ID: 36751553
[TBL] [Abstract][Full Text] [Related]
11. Barth Syndrome: Psychosocial Impact and Quality of Life Assessment.
Bath A; Akbilgic O; Wilbanks D; Patel J; Wallen M; Haji S; Das A; Alexander J; Pour-Ghaz I; Alkhatib D; Huang Y; Lontok E; Jefferies J
J Cardiovasc Dev Dis; 2022 Dec; 9(12):. PubMed ID: 36547445
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of SS-31 peptide on cardiac mitochondrial dysfunction in tafazzin knockdown mice.
Russo S; De Rasmo D; Signorile A; Corcelli A; Lobasso S
Sci Rep; 2022 Nov; 12(1):19847. PubMed ID: 36400945
[TBL] [Abstract][Full Text] [Related]
13. Stimulating the sir2-spargel axis rescues exercise capacity and mitochondrial respiration in a Drosophila model of Barth syndrome.
Damschroder D; Zapata-Pérez R; Richardson K; Vaz FM; Houtkooper RH; Wessells R
Dis Model Mech; 2022 Oct; 15(10):. PubMed ID: 36107830
[TBL] [Abstract][Full Text] [Related]
14. Barth Syndrome Cardiomyopathy: An Update.
Pang J; Bao Y; Mitchell-Silbaugh K; Veevers J; Fang X
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456462
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyopathies in Children and Systemic Disorders When Is It Useful to Look beyond the Heart?
Lodato V; Parlapiano G; Calì F; Silvetti MS; Adorisio R; Armando M; El Hachem M; Romanzo A; Dionisi-Vici C; Digilio MC; Novelli A; Drago F; Raponi M; Baban A
J Cardiovasc Dev Dis; 2022 Jan; 9(2):. PubMed ID: 35200700
[TBL] [Abstract][Full Text] [Related]
16. An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio.
Vaz FM; van Lenthe H; Vervaart MAT; Stet FS; Klinkspoor JH; Vernon HJ; Goorden SMI; Houtkooper RH; Kulik W; Wanders RJA
J Inherit Metab Dis; 2022 Jan; 45(1):29-37. PubMed ID: 34382226
[TBL] [Abstract][Full Text] [Related]
17. Methods of Generating Dielectrophoretic Force for Microfluidic Manipulation of Bioparticles.
Kwizera EA; Sun M; White AM; Li J; He X
ACS Biomater Sci Eng; 2021 Jun; 7(6):2043-2063. PubMed ID: 33871975
[TBL] [Abstract][Full Text] [Related]
18. Cardiolipin, Mitochondria, and Neurological Disease.
Falabella M; Vernon HJ; Hanna MG; Claypool SM; Pitceathly RDS
Trends Endocrinol Metab; 2021 Apr; 32(4):224-237. PubMed ID: 33640250
[TBL] [Abstract][Full Text] [Related]
19. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.
Zegallai HM; Hatch GM
Mol Cell Biochem; 2021 Mar; 476(3):1605-1629. PubMed ID: 33415565
[TBL] [Abstract][Full Text] [Related]
20. Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins.
Duncan AL
Biochem Soc Trans; 2020 Jun; 48(3):993-1004. PubMed ID: 32453413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
